Arialys Therapeutics

News

December 6, 2023

Arialys Presents at ACNP Annual Meeting 2023

At the ACNP 62nd Annual Meeting, Mickey Matsumoto, Ph.D., Chief Scientific Officer of Arialys, gave a Hot Topic Presentation entitled, "Monoclonal Humanized One-Armed Antibody Blocking Therapy for Anti-NMDA Receptor Autoantibody-Mediated CNS Disorders."

Click here to view the abstract (P543).

View the presentation here.

Sign up for news updates

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

News

Sign up for news updates

Follow us